{"id":6855,"date":"2023-06-09T10:25:00","date_gmt":"2023-06-09T10:25:00","guid":{"rendered":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-6\/"},"modified":"2023-06-09T10:25:00","modified_gmt":"2023-06-09T10:25:00","slug":"kommunike-fran-arsstamma-i-nanexa-6","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-6\/","title":{"rendered":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa"},"content":{"rendered":"
\n

Den 9 juni 2023 h\u00f6lls \u00e5rsst\u00e4mma i Nanexa AB (publ), varvid st\u00e4mman beslutade i enlighet med framlagda f\u00f6rslag. De fullst\u00e4ndiga beslutsf\u00f6rslagen framg\u00e5r av kallelsen till st\u00e4mman.<\/strong><\/p>\n<\/div>\n

\n

Resultat- och balansr\u00e4kning godk\u00e4ndes tillsammans med styrelsens f\u00f6rslag till disposition av bolagets resultat. Styrelsen och VD beviljades ansvarsfrihet f\u00f6r r\u00e4kenskaps\u00e5ret 2022.<\/p>\n

Till styrelseledam\u00f6ter omvaldes G\u00f6ran Ando, Richard Davis, Eva Nilsag\u00e5rd, Birgit Stattin Norinder och Magnus Westgren samt nyval av Jakob Dynnes Hansen. G\u00f6ran Ando omvaldes till styrelseordf\u00f6rande.<\/p>\n

St\u00e4mman beslutade om arvoden till styrelsen i enlighet med valberedningens f\u00f6rslag enligt f\u00f6ljande:<\/p>\n

Styrelsens ordf\u00f6rande erh\u00e5ller ett arvode om 260 000 kronor och \u00f6vriga ledam\u00f6ter, som inte \u00e4r anst\u00e4llda av bolaget, erh\u00e5ller ett arvode om 130 000 kronor. Vidare utg\u00e5r ett arvode till revisionsutskottets ordf\u00f6rande om 100 000 kronor och till \u00f6vriga ledam\u00f6ter i revisionsutskottet ett arvode om 50 000 kronor.<\/p>\n

Till revisor uts\u00e5gs \u00d6hrlings PricewaterhouseCoopers AB. Niclas Bergenmo kommer att forts\u00e4tta i rollen som huvudansvarig revisor.<\/p>\n

Valberedningens f\u00f6rslag till beslut om inr\u00e4ttande av valberedning och valberedningsinstruktion godk\u00e4ndes.<\/p>\n

Enligt styrelsens f\u00f6rslag beslutade st\u00e4mman om \u00e4ndrad lydelse av bolagsordningens best\u00e4mmelser r\u00f6rande gr\u00e4nserna f\u00f6r bolagets aktiekapital, antal aktier och r\u00e4tt att delta p\u00e5 st\u00e4mman.<\/p>\n

St\u00e4mman beslutade \u00e4ven att anta styrelsens f\u00f6rslag om bemyndiganden f\u00f6r styrelsen att besluta om f\u00f6retr\u00e4desemission samt riktad emission.<\/p>\n

Vidare beslutade st\u00e4mman att inr\u00e4tta ett teckningsoptionsbaserat incitamentsprogram som omfattar samtliga anst\u00e4llda i bolaget, i enlighet med styrelsens f\u00f6rslag.<\/p>\n<\/div>\n

\n

F\u00f6r mer information kontakta:<\/strong><\/p>\n

\n

David Westberg \u2013 VD, Nanexa AB (publ)\u00a0
Telefon: 0709-42 83 03
E-post:\u00a0david.westberg@nanexa.se<\/a>
www.nanexa.com<\/a><\/p>\n

Erik Penser Bank \u00e4r bolagets Certified Adviser och n\u00e5s p\u00e5 08-463 83 00, e-post: certifiedadviser@penser.se<\/p>\n<\/div>\n

\n

Om Nanexa AB (publ)<\/strong><\/p>\n

\n

Nanexa \u00e4r ett l\u00e4kemedelsbolag som utvecklar injicerbara l\u00e4kemedel baserade p\u00e5 det patenterade och innovativa drug delivery-systemet PharmaShell\u00ae \u2013 ett system som m\u00f6jligg\u00f6r n\u00e4sta generations l\u00e5ngverkande injicerbara l\u00e4kemedel med h\u00f6g drug load, tillverkade med atomlagerprecision. Nanexa utvecklar egna produkter och har dessutom samarbetsavtal med flera l\u00e4kemedelsbolag, d\u00e4ribland Novo Nordisk och AstraZeneca.<\/p>\n

Nanexas aktie \u00e4r noterad p\u00e5 Nasdaq First North Growth Market i Stockholm (NANEXA).<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Den 9 juni 2023 h\u00f6lls \u00e5rsst\u00e4mma i Nanexa AB (publ), varvid st\u00e4mman beslutade i enlighet med framlagda f\u00f6rslag. De fullst\u00e4ndiga beslutsf\u00f6rslagen framg\u00e5r av kallelsen till st\u00e4mman.<\/p>\n","protected":false},"template":"","class_list":["post-6855","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-ci-gm_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn-regulatory-listing_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-gm-info_sv","mfn-news-tag-mfn-regulatory_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nKommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-6\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Den 9 juni 2023 h\u00f6lls \u00e5rsst\u00e4mma i Nanexa AB (publ), varvid st\u00e4mman beslutade i enlighet med framlagda f\u00f6rslag. De fullst\u00e4ndiga beslutsf\u00f6rslagen framg\u00e5r av kallelsen till st\u00e4mman.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-6\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/kommunike-fran-arsstamma-i-nanexa-6\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/kommunike-fran-arsstamma-i-nanexa-6\\\/\",\"name\":\"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2023-06-09T10:25:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/kommunike-fran-arsstamma-i-nanexa-6\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/kommunike-fran-arsstamma-i-nanexa-6\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/kommunike-fran-arsstamma-i-nanexa-6\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-6\/","og_locale":"sv_SE","og_type":"article","og_title":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa - Nanexa AB","og_description":"Den 9 juni 2023 h\u00f6lls \u00e5rsst\u00e4mma i Nanexa AB (publ), varvid st\u00e4mman beslutade i enlighet med framlagda f\u00f6rslag. De fullst\u00e4ndiga beslutsf\u00f6rslagen framg\u00e5r av kallelsen till st\u00e4mman.","og_url":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-6\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-6\/","url":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-6\/","name":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2023-06-09T10:25:00+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-6\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-6\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-6\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/6855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=6855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}